Phillip Mark Hogarth

Title: The Innovations of Phillip Mark Hogarth

Introduction

Phillip Mark Hogarth is a notable inventor based in Williamstown, Australia. He has made significant contributions to the field of biochemistry, particularly in the development of multimeric Fc receptor polypeptides. With a total of 3 patents to his name, his work has implications for treating immune-complex mediated inflammatory diseases.

Latest Patents

Hogarth's latest patents focus on a soluble multimeric protein or polypeptide that inhibits the interaction of leukocyte Fcγ receptors (FcγR) and immunoglobulin G (IgG). This innovative protein comprises two or more linked Fc binding regions, with at least one derived from an FcγR type receptor, specifically FcγRIIa. Additionally, he has described polynucleotide molecules encoding this protein and its use in therapeutic methods for treating subjects with immune-complex mediated inflammatory diseases.

Career Highlights

Throughout his career, Phillip Mark Hogarth has worked with several prominent companies, including Trillium Therapeutics Inc. and Suppremol GmbH. His expertise in the field has allowed him to contribute to groundbreaking research and development in immunology.

Collaborations

Hogarth has collaborated with notable professionals in his field, including Bruce David Wines and Patricia Lesley Mottram. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Phillip Mark Hogarth's contributions to the field of biochemistry and immunology are significant, particularly through his innovative patents and collaborations. His work continues to influence the development of treatments for inflammatory diseases.